Effects of intermittent fasting on HbA1c and weight in insulin versus oral hypoglycemic therapy-treated patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Key Points

• Intermittent fasting shows promise in reducing HbA1c levels in patients undergoing oral hypoglycemic therapy.
• The meta-analysis revealed a significant weight loss effect linked to intermittent fasting in type 2 diabetes treatment.
• Systematic review included diverse studies evaluating the impact of dietary interventions on diabetes management.
• Findings suggest optimizing diabetes treatment could benefit from integrating intermittent fasting strategies.

Abstract